Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Commentary Volume 6 Issue 1

n-Covid Drugs and their Relevance in Present Day Scenario

D Narsimhaswamy1, Kurra Mohan2 and Ravi Varala3*

112001, Belcher Rd S; Apt No: N226, Largo Florida, USA
2Department of Pharmaceutical Chemistry, Telangana University, Nizamabad, Telangana, India
3Scrips Pharma, Mallapur, Hyderabad, Telangana, India

*Corresponding Author: Ravi Varala, Scrips Pharma, Mallapur, Hyderabad, Telangana, India.

Received: November 30, 2021; Published: December 20, 2021

Abstract

This commentary briefly discusses the necessity of utilizing repurposed drugs/vaccines to combat against evil covid-19. As new variants are (such as Omicron) emerging out due to undergoing mutations by virus, urge of developing more efficient drugs is necessary both in terms of efficacy and safety.

Keywords: n-Covid; Vaccines; Efficacy; Safety; Mutations; Variants; Drugs; Repurpose

References

  1. Zhu N., et al. The New England Journal of Medicine 8 (2020): 727-733.
  2. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  3. Varala R., et al. Coronaviruses 1 (2020): 9-12.
  4. Varala R., et al. Research Journal of Chemical Sciences 1 (2021): 84-86.
  5. Varala R., et al. Caribbean Journal of Science and Technology 1 (2021): 9-12.
  6. Swee Li., et al. Mini-Reviews in Medicinal Chemistry 10 (2021): 1173-1181.
  7. Gokada MR., et al. Journal of Evidence-Based Integrative Medicine 26 (2021): 1-8.
  8. Khan M., et al. Molecules1 (2021): 39.

Citation

Citation: Ravi Varala., et al. “n-Covid Drugs and their Relevance in Present Day Scenario". Acta Scientific Pharmaceutical Sciences 6.1 (2022): 113-115.

Copyright

Copyright: © 2022 Ravi Varala., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US